Xiaosong Meng
Papers
6
Total Citations
170
H-Index
6
About
Xiaosong Meng is a urologic surgeon and researcher whose work centers on minimally invasive surgical oncology, with a particular focus on upper tract urothelial carcinoma (UTUC) and robotic surgical techniques. His most significant contributions have emerged through the ROBUUST (Robotic Surgery for Upper Tract Urothelial Cancer Study) collaborative, a landmark multicenter international registry that has fundamentally shaped understanding of surgical approaches to UTUC. His most-cited work, a propensity-score matched "tetrafecta" analysis comparing robotic and laparoscopic nephroureterectomy (58 citations), demonstrated nuanced outcome differences between these techniques across 17 institutions worldwide. Complementary studies examining lymph node dissection outcomes (29 citations) and overall utilization trends (35 citations) have further established his role as a leading voice in this subspecialty. Meng's research consistently emphasizes rigorous comparative methodology and real-world clinical applicability, with additional work exploring robotic excision of retroperitoneal recurrences and perioperative intravesical chemotherapy practices. Collectively accumulating over 170 citations, his body of work has meaningfully influenced surgical decision-making for a disease that, while representing only 5% of urothelial malignancies, carries significant management complexity and oncologic consequence.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Oncologic outcomes of radical nephroureterectomy (RNU)34 citations · 2020
- 4
- 5
- 6